@article{1f05a31b9d174663acebd50324aef40e,
title = "Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohn's disease.",
author = "\{van der Woude\}, C.J. and P. Stokkers and \{van Bodegraven\}, A.A. and \{van Assche\}, G. and Z. Hebzda and L. Paradowski and G. D'Haens and S. Ghosh and B. Feagan and P. Rutgeerts and G. Dijkstra and \{de Jong\}, D.J. and B. Oldenburg and M. Farhan and T. Richard and Y. Dean and D.W. Hommes",
year = "2010",
language = "Undefined/Unknown",
volume = "16",
pages = "1708--1716",
journal = "Inflammatory bowel diseases",
issn = "1078-0998",
publisher = "Oxford University Press",
number = "10",
}